drugset / Trial / NCT01918930

Tissue Procurement Substudy for Participants in Study CP-MGA271-01

NCT01918930

NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to gain a better understanding about how the study drug MGA271 works. No test drug will be given in this study. Patients with easily accessible tumors at the screening visit for participation in Study CP-MGA271-01 will be asked to participate in this substudy. Patients will undergo two excisional biopsies, punch biopsies, or core needle biopsies.

Timeline

Start
2013-07
Primary completion
2016-10
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Enoblituzumab Monoclonal antibody

Indications